We commonly use BPC-157 as part of our treatment for the following conditions: Chronic gastrointestinal (GI) issues, including colitis, Crohns disease, irritable bowel disease (IBD), gastritis, ulcers, and esophagitis
Only two participants had a missing primary outcome, which was imputed using MICE
TB-500 dosing less characterized Important: These are experimental doses used in animal studies and cannot be extrapolated to other species due to significant differences in metabolism, receptor density, pharmacokinetics, and peptide degradation rates
Dosing precision
Visit the site and read the current certificates before you order
Price unavailable In vitro research use only Not for human or animal use blends Out of Stock GLOW (GHK-Cu 50mg / TB-500 10mg / BPC-157 10mg) Multi-peptide blend GLOW is a pre-formulated research blend combining GHK-Cu, TB-500, and BPC-157 for studies examining extracellular matrix signaling, cytoskeletal dynamics, and cellular repair pathways